Unknown

Dataset Information

0

Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D.


ABSTRACT: Hydrochlorothiazide, an effective antihypertensive medication commonly prescribed to blacks, decreases urinary calcium excretion. Blacks have significantly higher rates of hypertension and lower levels of 25-hydroxyvitamin D. Thus, they are more likely to be exposed to vitamin D supplementation and thiazide diuretics. The risk for hypercalcemia among blacks using vitamin D and hydrochlorothiazide is undefined.We assessed the frequency of hypercalcemia in hydrochlorothiazide users in a post hoc analysis of a randomized, double-blind, dose-finding trial of 328 blacks (median age 51 years) assigned to either placebo, or 1000, 2000, or 4000 international units of cholecalciferol (vitamin D3) daily for 3 months during the winter (2007-2010).Of the 328 participants, 84 reported hydrochlorothiazide use and had serum calcium levels assessed. Additionally, a comparison convenience group of 44 enrolled participants who were not taking hydrochlorothiazide had serum calcium measurements at 3 months, but not at baseline. At 3 months, hydrochlorothiazide participants had higher calcium levels (0.2 mg/dL, P <.001) than nonhydrochlorothiazide participants, but only one participant in the hydrochlorothiazide group had hypercalcemia. In contrast, none of the nonhydrochlorothiazide participants had hypercalcemia. In a linear regression model adjusted for age, sex, 25-hydroxyvitamin D at 3 months, and other covariates, only hydrochlorothiazide use (Estimate [SE]: 0.05 [0.01], P = .01) predicted serum calcium at 3 months.In summary, vitamin D3 supplementation up to 4000 IU in hydrochlorothiazide users is associated with an increase in serum calcium but a low frequency of hypercalcemia. These findings suggest that participants of this population can use hydrochlorothiazide with up to 4000 IU of vitamin D3 daily and experience a low frequency of hypercalcemia.

SUBMITTER: Chandler PD 

PROVIDER: S-EPMC4127365 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Introduction</h4>Hydrochlorothiazide, an effective antihypertensive medication commonly prescribed to blacks, decreases urinary calcium excretion. Blacks have significantly higher rates of hypertension and lower levels of 25-hydroxyvitamin D. Thus, they are more likely to be exposed to vitamin D supplementation and thiazide diuretics. The risk for hypercalcemia among blacks using vitamin D and hydrochlorothiazide is undefined.<h4>Methods</h4>We assessed the frequency of hypercalcemia in hydr  ...[more]

Similar Datasets

| S-EPMC5045493 | biostudies-literature
| S-EPMC7721737 | biostudies-literature
| S-EPMC3775458 | biostudies-literature
| S-EPMC5417600 | biostudies-literature
2024-11-25 | GSE282275 | GEO
| S-EPMC5872686 | biostudies-literature
| S-EPMC4209182 | biostudies-literature
| S-EPMC5407844 | biostudies-literature
| S-EPMC10116893 | biostudies-literature
| S-EPMC6030535 | biostudies-literature